TY - JOUR AU - Slichenmyer, W. J. AU - Von Hoff, D. D. PY - 1991 DA - 1991// TI - Taxol: a new and effective anti-cancer drug JO - Anticancer Drugs VL - 2 UR - https://doi.org/10.1097/00001813-199112000-00002 DO - 10.1097/00001813-199112000-00002 ID - Slichenmyer1991 ER - TY - JOUR AU - Vici, P. AU - Conti, F. AU - Amodio, A. AU - Belli, F. AU - Della Giulia, M. AU - Mariotti, S. AU - Gionfra, T. AU - Lopez, M. PY - 1998 DA - 1998// TI - Simultaneous infusion of vinorelbin and taxol as first-line chemotherapy in metastasized breast cancer JO - Clin Ter VL - 149 ID - Vici1998 ER - TY - JOUR AU - Hájek, R. AU - Vorlicek, J. AU - Slavik, M. PY - 1996 DA - 1996// TI - Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview JO - Neoplasma VL - 43 ID - Hájek1996 ER - TY - JOUR AU - Young, R. C. PY - 2000 DA - 2000// TI - Three cycles versus six cycles of adjuvant paclitaxel (Taxol)/carboplatin in early stage ovarian cancer JO - Semin Oncol VL - 27 ID - Young2000 ER - TY - JOUR AU - Choi, Y. H. AU - Yoo, Y. H. PY - 2012 DA - 2012// TI - Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells JO - Oncol Rep VL - 28 ID - Choi2012 ER - TY - JOUR AU - Zaniboni, A. AU - Ardizzoni, A. AU - De Marinis, F. AU - Portalone, L. AU - Boni, C. AU - Meriggi, F. AU - Cafferata, M. A. AU - Ariganello, O. AU - Torri, V. AU - Neumaier, C. E. AU - Rosso, R. PY - 2003 DA - 2003// TI - Phase II study of Taxol combi.ned With ifosfamide and carboplatin in the treatment of stage IIIb-IV non-small-cell lung cancer JO - Am J Clin Oncol VL - 26 UR - https://doi.org/10.1097/00000421-200302000-00016 DO - 10.1097/00000421-200302000-00016 ID - Zaniboni2003 ER - TY - JOUR AU - Chiou, J. F. AU - Liang, J. A. AU - Hsu, W. H. AU - Wang, J. J. AU - Ho, S. T. AU - Kao, A. PY - 2003 DA - 2003// TI - Comparing the relationship of Taxol-based chemotherapy response with P-glycoprotein and lung resistance-related protein expression in non-small cell lung cancer JO - Lung VL - 181 UR - https://doi.org/10.1007/s00408-003-1029-7 DO - 10.1007/s00408-003-1029-7 ID - Chiou2003 ER - TY - JOUR AU - Agarwal, R. AU - Kaye, S. B. PY - 2003 DA - 2003// TI - Ovarian cancer: strategies for overcoming resistance to chemotherapy JO - Nat Rev Cancer VL - 3 UR - https://doi.org/10.1038/nrc1123 DO - 10.1038/nrc1123 ID - Agarwal2003 ER - TY - JOUR AU - Lai, D. AU - Ho, K. C. AU - Hao, Y. AU - Yang, X. PY - 2011 DA - 2011// TI - Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-10-2711 DO - 10.1158/0008-5472.CAN-10-2711 ID - Lai2011 ER - TY - JOUR AU - Umezu, T. AU - Shibata, K. AU - Kajiyama, H. AU - Terauchi, M. AU - Ino, K. AU - Nawa, A. AU - Kikkawa, F. PY - 2008 DA - 2008// TI - Taxol resistance among the different histological subtypes of ovarian cancer may be associated with the expression of class III beta-tubulin JO - Int J Gynecol Pathol VL - 27 ID - Umezu2008 ER - TY - JOUR AU - Bai, Z. G. AU - Qu, X. AU - Han, W. AU - Ma, X. M. AU - Zhao, X. M. AU - Zhang, Z. T. PY - 2010 DA - 2010// TI - Expression of taxol resistance gene 1 correlates with gastric cancer patient clinical outcome and induces taxol resistance JO - Mol Med Report VL - 3 ID - Bai2010 ER - TY - JOUR AU - Wani, M. C. AU - Taylor, H. L. AU - Wall, M. E. AU - Coggon, P. AU - McPhail, A. T. PY - 1971 DA - 1971// TI - Plant antitumor agents. The isolation and structure of taxol, a novel antileukemic and antitumor agent from taxus brevifolia JO - J Am Chem Soc VL - 93 UR - https://doi.org/10.1021/ja00738a045 DO - 10.1021/ja00738a045 ID - Wani1971 ER - TY - JOUR AU - Radulescu, S. AU - Ridgway, R. A. AU - Appleton, P. AU - Kroboth, K. AU - Patel, S. AU - Woodgett, J. AU - Taylor, S. AU - Nathke, I. S. AU - Sansom, O. J. PY - 2010 DA - 2010// TI - Defining the role of APC in the mitotic spindle checkpoint in vivo: APC-deficient cells are resistant to Taxol JO - Oncogene VL - 29 UR - https://doi.org/10.1038/onc.2010.373 DO - 10.1038/onc.2010.373 ID - Radulescu2010 ER - TY - JOUR AU - Hornick, J. E. AU - Bader, J. R. AU - Tribble, E. K. AU - Trimble, K. AU - Breunig, J. S. AU - Halpin, E. S. AU - Vaughan, K. T. AU - Hinchcliffe, E. H. PY - 2008 DA - 2008// TI - Live-cell analysis of mitotic spindle formation in taxol-treated cells JO - Cell Motil Cytoskeleton VL - 65 UR - https://doi.org/10.1002/cm.20283 DO - 10.1002/cm.20283 ID - Hornick2008 ER - TY - JOUR AU - Xing, H. AU - Wang, S. AU - Weng, D. AU - Chen, G. AU - Yang, X. AU - Zhou, J. AU - Xu, G. AU - Lu, Y. AU - Ma, D. PY - 2007 DA - 2007// TI - Knock-down of P-glycoprotein reverses taxol resistance in ovarian cancer multicellular spheroids JO - Oncol Rep VL - 17 ID - Xing2007 ER - TY - JOUR AU - Gazitt, Y. AU - Rothenberg, M. L. AU - Hilsenbeck, S. G. AU - Fey, V. AU - Thomas, C. AU - Montegomrey, W. PY - 1998 DA - 1998// TI - Bcl-2 overexpression is associated with resistance to paclitaxel, but not gemcitabine, in multiple myeloma cells JO - Int J Oncol VL - 13 ID - Gazitt1998 ER - TY - JOUR AU - Panvichian, R. AU - Orth, K. AU - Day, M. L. AU - Day, K. C. AU - Pilat, M. J. AU - Pienta, K. J. PY - 1998 DA - 1998// TI - Paclitaxel-associated multimininucleation is permitted by the inhibition of caspase activation: a potential early step in drug resistance JO - Cancer Res VL - 15 ID - Panvichian1998 ER - TY - JOUR AU - Li, L. AU - Jiang, A. C. AU - Dong, P. AU - Wang, H. AU - Xu, W. AU - Xu, C. PY - 2009 DA - 2009// TI - MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol JO - Ann Surg Oncol VL - 16 UR - https://doi.org/10.1245/s10434-009-0395-7 DO - 10.1245/s10434-009-0395-7 ID - Li2009 ER - TY - JOUR AU - Kavallaris, M. AU - Burkhart, C. A. AU - Horwitz, S. B. PY - 1999 DA - 1999// TI - Antisense of Ligonucleotides to class βII- tubulin sensitive drug-resistant cells to Taxol JO - Br J Cancer VL - 80 UR - https://doi.org/10.1038/sj.bjc.6690507 DO - 10.1038/sj.bjc.6690507 ID - Kavallaris1999 ER - TY - JOUR AU - Mao, Q. Q. AU - Bai, Y. AU - Lin, Y. W. AU - Zheng, X. Y. AU - Qin, J. AU - Yang, K. AU - Xie, L. P. PY - 2010 DA - 2010// TI - Resveratrol confers resistance against taxol via induction of cell cycle arrest in human cancer cell lines JO - Mol Nutr Food Res VL - 54 UR - https://doi.org/10.1002/mnfr.200900392 DO - 10.1002/mnfr.200900392 ID - Mao2010 ER - TY - JOUR AU - Wang, T. H. AU - Wang, H. S. AU - Soong, Y. K. PY - 2000 DA - 2000// TI - Paclitaxel-induced cell death: where the cell cycle and apoptosis come together JO - Cancer VL - 1 UR - https://doi.org/3.0.CO;2-J DO - 3.0.CO;2-J ID - Wang2000 ER - TY - JOUR AU - Edgar, B. A. AU - Sprenger, F. AU - Duronio, R. J. AU - Leopold, P. AU - O’Farrell, P. H. PY - 1994 DA - 1994// TI - Distinct molecular mechanism regulate cell cycle timing at successive stages of Drosophila embryogenesis JO - Genes Dev VL - 15 UR - https://doi.org/10.1101/gad.8.4.440 DO - 10.1101/gad.8.4.440 ID - Edgar1994 ER - TY - JOUR AU - Mohamed, F. Z. AU - Hussien, Y. M. AU - Albakry, M. M. AU - Mohamed, R. H. AU - Said, N. M. PY - 2013 DA - 2013// TI - Role of DNA repair and cell cycle control genes in ovarian cancer susceptibility JO - Mol Biol Rep VL - 40 UR - https://doi.org/10.1007/s11033-012-2452-8 DO - 10.1007/s11033-012-2452-8 ID - Mohamed2013 ER - TY - JOUR AU - Rastogi, N. AU - Mishra, D. P. PY - 2012 DA - 2012// TI - Therapeutic targeting of cancer cell cycle using proteasome inhibitors JO - Cell Div VL - 26 ID - Rastogi2012 ER - TY - JOUR AU - Long, B. H. AU - Fairchild, C. R. PY - 1994 DA - 1994// TI - Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase JO - Cancer Res VL - 15 ID - Long1994 ER - TY - JOUR AU - Lee, E. A. AU - Keutmann, M. K. AU - Dowling, M. L. PY - 2004 DA - 2004// TI - Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells JO - Mol Cancer Ther VL - 3 ID - Lee2004 ER - TY - JOUR AU - Xue Dong, Y. AU - Min, L. AU - Ye, Y. AU - Ning, M. AU - Ling Ya, P. PY - 2007 DA - 2007// TI - Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations JO - Oncol Rep VL - 17 ID - Xue Dong2007 ER - TY - JOUR AU - Jordan, M. A. AU - Wilson, L. PY - 1998 DA - 1998// TI - Microtubules and actin filaments: dynamic targets for cancer chemotherapy JO - Curr Opin Cell Biol VL - 10 UR - https://doi.org/10.1016/S0955-0674(98)80095-1 DO - 10.1016/S0955-0674(98)80095-1 ID - Jordan1998 ER - TY - JOUR AU - Tsukasaki, K. AU - Miller, C. W. AU - Greenspun, E. AU - Eshaghian, S. AU - Kawabata, H. AU - Fujimoto, T. AU - Tomonaga, M. AU - Sawyers, C. AU - Said, J. W. AU - Koeffler, H. P. PY - 2001 DA - 2001// TI - Mutations in the mitotic check point gene, MAD1L1, in human cancers JO - Oncogene VL - 20 UR - https://doi.org/10.1038/sj.onc.1204421 DO - 10.1038/sj.onc.1204421 ID - Tsukasaki2001 ER - TY - JOUR AU - Shichiri, M. AU - Yoshinaga, K. AU - Hisatomi, H. AU - Sugihara, K. AU - Hirata, Y. PY - 2002 DA - 2002// TI - Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival JO - Cancer Res VL - 62 ID - Shichiri2002 ER - TY - JOUR AU - Musio, A. AU - Montagna, C. AU - Zambroni, D. AU - Indino, E. AU - Barbieri, O. AU - Citti, L. AU - Villa, A. AU - Ried, T. AU - Vezzoni, P. PY - 2003 DA - 2003// TI - Inhibition of BUB1 results in genomic instability and anchorage-independent growth of normal human fibroblasts JO - Cancer Res VL - 63 ID - Musio2003 ER - TY - JOUR AU - Hu, M. AU - Liu, Q. AU - Song, P. AU - Zhan, X. AU - Luo, M. AU - Liu, C. AU - Yang, D. AU - Cai, Y. AU - Zhang, F. AU - Jiang, F. AU - Zhang, Y. AU - Tang, M. AU - Zuo, G. AU - Zhou, L. AU - Luo, J. AU - Shi, Q. AU - Weng, Y. PY - 2013 DA - 2013// TI - Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells JO - Oncol Rep VL - 29 ID - Hu2013 ER - TY - JOUR AU - Masuda, A. AU - Maeno, K. AU - Nakagawa, T. PY - 2003 DA - 2003// TI - Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancers JO - Am J Pathol VL - 163 UR - https://doi.org/10.1016/S0002-9440(10)63470-0 DO - 10.1016/S0002-9440(10)63470-0 ID - Masuda2003 ER - TY - JOUR AU - Fu, Y. AU - Ye, D. AU - Chen, H. AU - Lu, W. AU - Ye, F. AU - Xie, X. PY - 2007 DA - 2007// TI - Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30 JO - Gynecol Oncol VL - 105 UR - https://doi.org/10.1016/j.ygyno.2006.10.061 DO - 10.1016/j.ygyno.2006.10.061 ID - Fu2007 ER - TY - JOUR AU - Gian, V. G. AU - Johnson, T. J. AU - Marsh, R. W. AU - Schuhmacher, C. AU - Lynch, J. W. PY - 1996 DA - 1996// TI - A phase II trial of paclitaxel in the treatment of recurrent or metastatic soft tissue sarcomas or bone sarcomas JO - J Exp Ther Oncol VL - 1 ID - Gian1996 ER - TY - JOUR AU - Patel, S. R. AU - Papadopoulos, N. E. AU - Plager, C. AU - Linke, K. A. AU - Moseley, S. H. AU - Spirindonidis, C. H. AU - Benjamin, R. PY - 1996 DA - 1996// TI - Phase II study of paclitaxel in patients with previously treated osteosarcoma and its variants JO - Cancer VL - 78 UR - https://doi.org/3.0.CO;2-H DO - 3.0.CO;2-H ID - Patel1996 ER - TY - JOUR AU - Ferlini, C. AU - Ojima, I. AU - Distefano, M. AU - Gallo, D. AU - Riva, A. AU - Morazzoni, P. AU - Bombardelli, E. AU - Mancuso, S. AU - Scambia, G. PY - 2003 DA - 2003// TI - Second generation taxanes: from the natural framework to the challenge of drug resistance JO - Curr Med Chem Anticancer Agents VL - 3 UR - https://doi.org/10.2174/1568011033353489 DO - 10.2174/1568011033353489 ID - Ferlini2003 ER -